Compound Evidence File
#EC-2026-0194
Minoxidil Oral
Filed under Oral Tablets. The bureau holds 154 laboratory returns for this compound from 55 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
55 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 10.0 | 10.0 | 6 Nov 2025 | 4 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Feb 2026 | 12 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Jan 2026 | 8 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 10.0 | 10.0 | 21 Jan 2026 | 17 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Feb 2026 | 3 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 10.0 | 10.0 | 4 Apr 2026 | 7 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 4 Jan 2026 | 13 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 27 Dec 2025 | 20 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 2 May 2026 | 17 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 24 Jan 2026 | 16 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Jan 2026 | 15 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Nov 2025 | 25 Apr 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Jul 2026 | 16 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 10.0 | 10.0 | 10.0 | 21 Feb 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 11 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 8 May 2026 | 12 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Feb 2026 | 24 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Jan 2026 | 3 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Jul 2026 | 4 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 12 Apr 2026 | 16 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Dec 2025 | 23 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 9.4 | 9.4 | 9.4 | 16 Mar 2025 | 16 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 9.2 | 8.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 9.2 | 9.2 | 9.2 | 27 Feb 2025 | 27 Feb 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 9.2 | 9.2 | 9.2 | 3 Jul 2025 | 3 Jul 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 3 | 8.8 | 8.3 | 9.4 | 3 Jun 2025 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.6 | 7.6 | 9.7 | 24 May 2026 | 24 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 8.3 | 8.3 | 8.3 | 21 May 2025 | 21 May 2025 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 8.1 | 8.1 | 8.1 | 11 Jun 2025 | 11 Jun 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 8.1 | 8.1 | 8.1 | 13 Jun 2025 | 13 Jun 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.0 | 7.6 | 8.3 | 21 May 2026 | 21 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 | 13 Feb 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 7.9 | 7.1 | 8.7 | 21 May 2026 | 21 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 7.8 | 6.4 | 9.4 | 25 May 2026 | 25 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 6 | 7.8 | 5.6 | 10.0 | 13 Jun 2025 | 24 May 2026 |
| NexaphCASE #VI-2026-0944 | X | 6 | 7.7 | 6.4 | 8.6 | 27 Feb 2025 | 21 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 4 | 7.6 | 6.2 | 9.0 | 2 Jul 2025 | 20 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 7.4 | 7.4 | 7.4 | 9 Jun 2025 | 9 Jun 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 2 | 6.8 | 6.2 | 7.3 | 20 Jun 2025 | 24 May 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 | 6 May 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 | 27 Feb 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 2 | 6.6 | 6.4 | 6.7 | 25 Apr 2025 | 24 May 2026 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Jul 2025 | 2 Jul 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 6.4 | 6.4 | 6.4 | 11 Jun 2025 | 11 Jun 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 1 | 5.6 | 5.6 | 5.6 | 14 Jan 2025 | 14 Jan 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 | 13 Jun 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 5.0 | 5.0 | 5.0 | 25 Apr 2025 | 25 Apr 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | X | 1 | 4.7 | 4.7 | 4.7 | 20 Jun 2025 | 20 Jun 2025 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 4.5 | 4.5 | 4.5 | 9 Jun 2025 | 9 Jun 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 3.4 | 3.4 | 3.4 | 27 Feb 2025 | 27 Feb 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 2.1 | 0.6 | 3.6 | 21 May 2025 | 24 May 2026 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
Open any subject to view the batch-level evidence for Minoxidil Oral alone.